Two medical journals publish retractions on two papers related to atorvastatin, brain bleeding
Two medical journals recently retracted a pair of papers about the possible use of atorvastatin to treat bleeding on the brain, Retraction Watch reports.
The website noted that the papers were published last year in the Journal of Neurosurgery and Frontiers in Neuroscience. The papers shared the following authors: Hua Liu, Zhongkun Liu, Jian Yang and Shifeng Kan.
Atorvastatin is used to treat high cholesterol and is the generic name for Lipitor, the blockbuster drug that lost patent protection in 2011.
Read the full article below:
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.